Oral vinorelbine: Feasibility and safety profile
Open Access
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier BV in Annals Of Oncology
- Vol. 12 (12), 1677-1681
- https://doi.org/10.1023/a:1013567022670
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patientsAnnals Of Oncology, 2001
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997
- Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer.Journal of Clinical Oncology, 1996
- Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.Journal of Clinical Oncology, 1995
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals Of Oncology, 1994
- Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.Journal of Clinical Oncology, 1993
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991